五种前列腺穿刺活检方式的成本与效能比较
该研究比较了五种前列腺穿刺活检方式的综合成本与效能,发现与标准经直肠超声引导活检相比,镇静下经直肠、经会阴模板、MRI-TRUS融合及MRI内活检的总成本显著增加,但融合活检和经会阴模板活检检出更多显著癌。
要点
- 镇静TRUS、经会阴模板、融合活检和MRI内活检的成本分别是标准TRUS的1.9、2.5、2.5和2.2倍。
- 融合活检和经会阴模板活检的显著癌检出率高于标准TRUS(36% vs 16%,34% vs 16%)。
- 结合影像与经会阴活检,尤其在门诊/局部麻醉下,可能提高成本效益。
核心结论
- 与标准经直肠超声引导活检相比,增加影像、镇静麻醉和经会阴模板会显著增加成本,但可结合已知的准确性和副作用改善来考虑。
研究设计与样本
- 研究比较了五种前列腺活检方式的综合成本,每种随机抽取20-30例,并比较了TRUS-BX、TP和FB更大队列的手术结局。
主要发现
- 镇静TRUS-BX、TP、FB和IB-MRI的总成本分别是标准TRUS-BX的1.9倍(90%)、2.5倍(153%)、2.5倍(150%)和2.2倍(125%)(p < 0.001)。
- TP、FB和IB-MRI的总成本之间无统计学差异,但均显著高于局部麻醉或镇静下的TRUS-BX(p < 0.05)。
- 镇静下TRUS-BX的成本显著高于局部麻醉下TRUS-BX(p < 0.001)。
- 与TRUS-BX相比,FB组(16% vs. 36%)和TP组(16% vs. 34%)检出更多显著癌(p < 0.001)。
临床怎么用
- 临床选择前列腺活检方式时,应综合考虑成本增加与准确性和副作用改善,尤其在门诊局部麻醉下结合影像与经会阴活检可能提高成本效益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The cornerstone of prostate cancer diagnosis remains the transrectal ultrasound-guided biopsy (TRUS-BX), which most frequently occurs in the office setting under local anesthesia. However, there are now other techniques of prostate biopsy aimed at improving outcomes such as patient comfort, significant cancer detection, and infectious complications. The purpose of the present study is to compare the cost and efficacy outcomes of five different approaches. METHODS: We compared the comprehensive costs of a random sample size of 20-30 cases from each of the following: (1) local anesthesia TRUS-BX (reference), (2) sedation TRUS-BX, (3) general anesthesia transperineal template biopsy (TP), (4) sedation MRI-TRUS fusion biopsy (FB), and (5) sedation in-bore MRI biopsy (IB-MRI). Cost categories included pre-procedure, anesthesia pharmacy and recovery, and the technical/professional costs from urology, radiology, and pathology services. For procedure outcomes, we compared the larger cohorts of TRUS-BX, TP, and FB in terms of indication, cancer yield, and downstream decision impact. RESULTS: Compared with standard TRUS-BX, the total costs of sedation TRUS-BX, TP, FB, and IB-MRI increased significantly ×1.9 (90%), ×2.5 (153%), ×2.5 (150%), and ×2.2 (125%), respectively (p < 0.001). Although there was no statistical difference between the total costs of TP, FB, and IB-MRI, these costs were significantly higher than those of TRUS-BX under either local anesthesia or sedation (p < 0.05). The cost of TRUS-BX under sedation was significantly higher than that of TRUS-BX under local anesthesia (p < 0.001). Compared to TRUS-BX, more significant cancers were detected in FB (16% vs. 36%) and TP (16% vs. 34%) groups (p < 0.001). CONCLUSIONS: Compared with standard TRUS-BX, the additions of imaging, sedation anesthesia, and transperineal template increase costs significantly, and can be considered along with known improvements in accuracy and side effects. Ongoing efforts to combine imaging and transperineal biopsy, especially in an outpatient/local anesthesia setting may lead to a higher cost/benefit.
引用
- Altok M, Kim B, Patel BB, et al. Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research. Prostate Cancer Prostatic Dis. 2018. PMID: 29988098. doi:10.1038/s41391-018-0056-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。